You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: August 14, 2024

FLUTICASONE PROPIONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Fluticasone Propionate patents expire, and what generic alternatives are available?

Fluticasone Propionate is a drug marketed by Cosette, Encube, Fougera Pharms, Nesher Pharms, Padagis Israel, Glenmark Pharms Ltd, Bright, Taro Pharm Inds, Apotex, Apotex Inc, Chartwell Rx, Hikma, and Teva Pharms Usa. and is included in twenty-one NDAs.

The generic ingredient in FLUTICASONE PROPIONATE is fluticasone propionate; salmeterol xinafoate. There are twenty-nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FLUTICASONE PROPIONATE?
  • What are the global sales for FLUTICASONE PROPIONATE?
  • What is Average Wholesale Price for FLUTICASONE PROPIONATE?
Drug patent expirations by year for FLUTICASONE PROPIONATE
Drug Prices for FLUTICASONE PROPIONATE

See drug prices for FLUTICASONE PROPIONATE

Drug Sales Revenue Trends for FLUTICASONE PROPIONATE

See drug sales revenues for FLUTICASONE PROPIONATE

Recent Clinical Trials for FLUTICASONE PROPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Eurofarma Laboratorios S.A.Phase 3
Humanis Saglık Anonim SirketiPhase 1
Emory UniversityPhase 3

See all FLUTICASONE PROPIONATE clinical trials

Pharmacology for FLUTICASONE PROPIONATE
Paragraph IV (Patent) Challenges for FLUTICASONE PROPIONATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FLOVENT HFA Inhalation Aerosol fluticasone propionate 0.22 mg/inh 021433 1 2021-10-29
FLOVENT HFA Inhalation Aerosol fluticasone propionate 0.11 mg/inh 021433 1 2016-12-23
CUTIVATE Lotion fluticasone propionate 0.05% 021152 1 2008-07-28

US Patents and Regulatory Information for FLUTICASONE PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette FLUTICASONE PROPIONATE fluticasone propionate CREAM;TOPICAL 077055-001 Jun 30, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma FLUTICASONE PROPIONATE fluticasone propionate SPRAY, METERED;NASAL 207957-001 May 26, 2016 OTC No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE fluticasone propionate; salmeterol xinafoate POWDER;INHALATION 213948-002 Dec 13, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Israel FLUTICASONE PROPIONATE fluticasone propionate LOTION;TOPICAL 091553-001 Jul 30, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Nesher Pharms FLUTICASONE PROPIONATE fluticasone propionate CREAM;TOPICAL 076865-001 Sep 10, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro Pharm Inds FLUTICASONE PROPIONATE fluticasone propionate OINTMENT;TOPICAL 077145-001 Jun 14, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.